About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles

Articles

Antithrombotic Therapy in Chronic Total Occlusion Interventions

Iosif Xenogiannis, Charalampos Varlamos, Despoina-Rafailia Benetou,

Published:

Citation: US Cardiology Review 2021;15:e10.

Antithrombotic Therapy in Complex PCI Patients Under OAC

Despoina-Rafailia Benetou, Panayotis K Vlachakis, Charalampos Varlamos,

Published:

Citation: US Cardiology Review 2021;15:e09.

MIDCAB, TECAB and Hybrid Coronary Revascularisation Surgery

Karel M Van Praet, Markus Kofler, Timo Z Nazari Shafti,

Published:

Citation: Interventional Cardiology Review 2021;16:e08.

Transcatheter Mitral Valve Replacement: Concepts and Evidence

Ozan M Demir, Mhairi Bolland, Jonathan Curio,

Published:

Citation: Interventional Cardiology Review 2021;16:e07.